$IMMB SWEET EMAILER JUST OUT IMMB Special Update Hot

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker

[b]$IMMB SWEET EMAILER JUST OUT >> IMMB Special Update

[/b]

Hot news just came out fron IMMB and guess what, the guy that just was put on the board is a stud ! Also the company mentioned it brought him in as part of the plans to go to NASDAQ. not the exact wording, but here check out today's press and good luck.

$IMMB NASDAQ Uplisting mentioned in PR http://finance.yahoo.com/news/immunotech-labo...00904.html

This type of exposure could be huge in the longterm.

Thomas Hitman Hearns - http://www.youtube.com/watch?v=4c2nwrvTORU&am...e=youtu.be

Sugar Ray Leonad - http://www.youtube.com/watch?v=TqAwgDEDVJ0&am...e=youtu.be

Cory Feldman Link - http://www.youtube.com/watch?v=QyH6tVKBUjg

Cleve Hall Link - http://www.youtube.com/watch?v=ZLcQ12GF0ao

Happy Trading

Video Link  first interview with Bo Linton -   http://www.youtube.com/watch?v=uCjNAf30aeo

Testimonials - www.lifechoicemx.com

Don't be greedy forward this email to a friend.  Can you imagine if everybody sent this email to 5-10 friends how happy your friends would be

A Breakthrough Treatment For HIV, Cancer and Aids Can Make Investors A Nice Profit.

Add Immunotech Laboratories to your watchlist right away.

Ticker IMMB

Hello new and existing subscribers.  Today we are profiling Immunotech Laboratorires ticker IMMB.  The Company produces treatments for patients that have HIV, Aids, Cancer and Hepatitis C.  Please note this is not just some 1 day profile deal here, PSPicks and several others are going to be profiling this for at least a month!

The Float Is About 1,000,000 Shares so this can really fly!

FDA Approval

IMMB just announced an LOI with an International Bio-Tech partner for USA clinical trials.  In other words they are moving towards FDA Approval.  Have you ever seen what happens to a stock after FDA Approval?  Stocks tend to shoot up big time when that happens.  I've seen some companies shoot up for 5000% or higher gains.  Now that would be nice huh?

Company Has Patented Technology

IMMB's  treatments are already patented.   Immunotech (IMMB) appears to be ahead of its competition in many aspects.

Check out the company website immunotechlab.com for detailed information

Treatments And Testimonials Already

When you are making profits trading IMMB you can really feel good about it because they are actually helping to treat these horrible diseases.

Go check out LifeChoiceMX.com right away.  This is a treatment center that is treating patients in Mexico right now with the immunotherapies.  There are actual video tesimonials of people that have been treated and cured.   Were not just talking about a potential treatment, these guys are actually doing it.  The company has also said they are planning on opening centers in Africa and Bulgaria.

Revenues In The Billions

There are 30 Million HIV Patients in Africa alone.  Let alone the rest of the world.  IMMB has indicated that they will be in the Billions in terms of revenues once approved.

Like I said we are going to be covering this one for a while, This is just the start.  Please start your research in these places

Company Website - ImmunotechLab.com

Treatment Center In Mexico - lifechoicemx.comt

Latest Press - http://finance.yahoo.com/news/immunotech-labo...00154.html

More To Come Good Luck !

***********************

Disclaimer

***********************

Notice, by subscribing to our newsletter or browsing our website you agree to the

following terms / conditions.

This marketing report, release, and/or advertisement is a commercial advertisement and

is only to be used for for general information purposes. Never invest in any security

featured on our site, emails, print and videos unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or

joining our email list.

PSPICKS.com, its employees and affiliates are not a Registered Investment Advisors,

Broker Dealers, or a member of any association for other research providers in any jurisdiction whatsoever.

PSPICKS.com is often times compensated to feature certain companies. Payments

typically come from a Third Party holding shares of a Company.  The third parties may

have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. All direct and third party compensation received will be disclosed within each individual email in accordance with section 17(b) of the 1933 Securities Act. Any compensation constitutes a conflict of interest as to our ability

to remain objective in our communication regarding the profiled companies.

Any Compensation for marketing is disclosed at the bottom of this email.

PSPICKS.com has not investigated the background of the third party, the hiring company. Anyone viewing our website and advertisements should assume that the hiring party and affiliates of the hiring party own shares of the profiled company of which they plan to liquidate, further understanding that the liquidation of those shares will most likely impact

the share price of the profiled company negatively. PSPICKS.com affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the share price of the security.

Release of Liability: Through use of this website, and/or ad campaign viewing or using

you agree to hold PSPICKS.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you

may incur. The information contained herein is based on sources that PSPICKS assume

to be reliable, but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. PSPICKS.com encourages readers and investors to supplement the information in these reports with independent research

and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and PSPICKS.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. FURTHERMORE, by accessing, viewing, or using

the website, communications, and advertisements originating from PSPICKS.com you

agree that PSPICKS.com, its owners, officers, directors, contractors, employees, and affiliates are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that PSPICKS.com, its owners, officers, directors, contractors, employees, and affiliates shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to

these sites are provided for your convenience only. PSPICKS.com uses third parties to disseminate information to subscribers. Although we take precautions to prevent others

from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. You agree to hold PSPICKS.com, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website, email, advertisements is at your sole risk. PSPICKS.com disclaims all warranties of any kind, express or implied.

Third Party Web Sites and Information

PSPICKS.com and newsletter may provide hyperlinks to third party websites or access to third party content. PSPICKS.com does not control, endorse, or guarantee content found in such sites. You agree that PSPICKS.com is not responsible for any content, associated

links, resources, or services associated with a third party site. You further agree that PSPICKS.com shall not be liable for any loss or damage of any sort associated with your

use of third party content. Links and access to these sites are provided for your

convenience only None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead PSPICKS.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. PSPICKS.com is compliant with the Can Spam Act of 2003. PSPICKS.com does not offer such advice or analysis, and PSPICKS.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

PSPICKS.com website, emails, and or advertisements may have forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of

risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”,

“estimates”, “believes”, “understands”, or that by statements indicating certain actions

“may”, “could”, or “might” occur. Understand there is no guarantee past performance

will be indicative of future results.

In preparing our publications, PSPICKS.com has relied upon information supplied by its customers, and press releases, which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this

website. Rather, investors should use the information contained in this website as a

starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, PSPICKS.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement.

PSPICKS.com is not responsible for any claims made by the companies advertised herein, nor is PSPICKS.com responsible for any other promotional firm, its program or its structure.

PSPicks expects to be compensated up to $75,000 for marketing services by Third Party.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 1

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Updated Category News Views 7

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

Continue Reading
Navigating Land Access: The Hidden Roadblock in Mining

Updated Category News Views 2

Mining's Often Overlooked Obstacle: Land Access In the world of mining, the shallow thrills of striking gold are often overshadowed by the frustrating slog of securing land access. You can have your permits lined up, your finances sorted, and drills humming along, but if you haven’t sweet-talked the folks farming above your visible vein of riches, you could be staring...

Continue Reading
Helio Fred Garcia Honored by Diversity Action Alliance

Updated Category News Views 4

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 1

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 4

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
AI Trust in Finance: Survey Reveals Market Impact

Updated Category News Views 2

Trust in AI for Financial Guidance: Where Are We Headed? The market winds shift with every sunrise, and today’s buzzword? Artificial Intelligence. You’d almost think AI’s trying to steal my job along with every other trader’s mojo. But here's the twist—A survey from Possible Finance shows about 15% of folks would actually lean on AI for their financial advice....

Continue Reading
Liberty Hill: 50 Years of Grassroots Revolution

Updated Category News Views 3

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 2

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
SES Sells to AFC Industries: A Strategic M&A Move

Updated Category News Views 0

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Continue Reading

Top 5 Most Recently Viewed Articles

Dynavax Encourages Support for Director Nominees Amid Changes

Updated Category News Views 112

Dynavax Urges Stockholders to Support Director Nominees Dynavax's Strategy is Delivering Significant Long-Term Stockholder Value Dynavax's Nominees Are Vastly Superior to Competitors' Candidates Across Every Critical Area Follow Recommendations of Proxy Advisory Firms and Vote "FOR" All Four of Dynavax's Director Nominees on the GOLD Proxy Card Today Dynavax Technologies...

Continue Reading
ION Achieves Landmark Certification for Algorithmic Trading

Updated Category News Views 171

ION Achieves Major Certification for Trading Software Globally recognized leader in trading technology, ION, has successfully secured certification as an Independent Software Vendor for algorithmic trading on BSE. This groundbreaking registration allows exchange members to leverage the advanced trading capabilities of ION's Fidessa trading platform, marking a pivotal step...

Continue Reading
ImmuCell Corporation Updates Lease and By-Laws: Key Insights

Updated Category News Views 128

ImmuCell Corporation Updates Lease Agreement and By-Laws ImmuCell Corporation (NASDAQ:ICCC) has embarked on a series of significant changes recently, including modifying the terms of its lease for the facility located in Portland, Maine. The company also took this opportunity to update its corporate by-laws, as revealed in a filing with the SEC. Revised Lease Agreement On...

Continue Reading
Navigating the Future of Zscaler: Options Insight and Performance

Updated Category News Views 157

Insights into Zscaler's Options Market Activity Recently, significant market players have exhibited a noticeably cautious outlook regarding Zscaler. The analysis of Zscaler's options history reveals intriguing patterns that might influence future trading decisions. Understanding the Options Trades In our examinations of the options trades associated with Zscaler (NASDAQ:...

Continue Reading
BPGbio Teams with Oxford University to Propel Protein Research Forward

Updated Category News Views 107

BPGbio and University of Oxford Collaborate on Groundbreaking Research BPGbio, Inc., a prominent, AI-driven clinical-stage biopharmaceutical company focusing on innovative mitochondrial biology and protein homeostasis, has officially entered into a strategic collaboration with the University of Oxford. This partnership aims to push the frontiers of research in protein...

Continue Reading